가와사끼병에서 정맥용 면역글로불린 불응군의 특성

키워드

참고문헌 (30)

1. Kawasaki T, "Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children", Jpn J Allergy, 16, pp.178~222 (1967)
2. Lee KY, "Kawasaki disease may be a hyperimmune reaction of genetically-susceptible children to variants of normal environmental flora", Med Hypotheses, 69, pp.642~651 (2007)
3. Burns JC, "Kawasaki syndrome", Lancet, 364, pp.533~544 (2004)
4. Newburger JW, "Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association", Pediatrics, 114, pp.1708~1733 (2004)
5. Furusho K, "High-dose intravenous gammaglobulin for Kawasaki disease", Lancet, 2, pp.1055~1058 (1984)
6. Newberger JW, "A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome", N Engl J Med, 324, pp.1633~1639 (1991)
7. Yanagawa H, "Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in japan", Arch Pediatr Adolesc Med, 149, pp.779~783 (1995)
8. Burns JC, "Intravenous gamma-globulin treatment and retreatment in Kawasaki disease: US", Canadian Kawasaki Syndrome Study Group, 1998, pp.17, 1144~1148
9. Wright DA, "Clinical and laboratory observations. Treatment of immunoglobulin-resistant Kawasaki disease with pulsed doses of corticosteroids", J Pediatr, 128, pp.146~149 (1996)
10. Mori M, "Predictors of coronary artery lesions after intravenous -globulin treatment in Kawasaki disease", J Pediatr, 137, pp.177~180 (2000)
11. Fukunishi M, "Prediction of non-responsiveness to intravenous high-dose γ- globulin therapy in patients with Kawasaki disease at onset", J Pediatr, 137, pp.172~176 (2000)
12. Egami K, "Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease", J Pediatr, 149, pp.237~240 (2006)
13. Sano T, "Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment", Eur J Pediatr, 166, pp.131~137 (2007)
14. Kobayashi T, "Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease", Circulation, 113, pp.2606~2612 (2006)
15. Nakano H, "Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease", Am J Cardiol, 56, pp.846~851 (1985)
16. Leung DY, "Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin", J Clin Invest, 79, pp.468~472 (1987)
17. Lee KY, "Immunoglobulin G has a role for systemic protein modulation in vivo: a new concept of protein homeostasis", Med Hypotheses, 67, pp.848~855 (2006)
18. Lee KY, "Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever", J Korean Med Sci, 19, pp.501~504 (2004)
19. Asai T, "Diagnosis and prognosis of coronary artery lesions in Kawasaki disease. Coronary angiography and the conditions for its application (a score chart) (Japanese)", Nippon Rhinsho, 41, pp.2080~2085 (1983)
20. Koren G, "Kawasaki disease:review of risk factors for coronary aneurysms", J Pediatr, 108, pp.388~392 (1986)
21. Beiser AS, "A predictive instrument for coronary artery aneuryms in Kawasaki disease", Am J Cardiol, 81, pp.1116~1120 (1998)
22. Koyanagi H, "Lower level of serum potassium and higher level of Creactive protein as an independent risk factor for giant aneurysms in Kawasaki disease", Acta Paediatr, 87, pp.32~36 (1998)
23. Lee KY, "Features of Kawasaki disease at the extreams of age", J Paediatr Child Health, 42, pp.423~427 (2006)
24. Hwang JY, "Laboratory profiles in patients with Kawasaki disease according to intravenous immunoglobulin responsiveness", Preceeding of the 9th International Kawasaki disease symposium, pp.166~ (2008)
25. Lee KY, "Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease", Acta Paediatr, 91, pp.64~67 (2002)
26. Lee KY, "High-dose intravenous immunoglobulin down regulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki disease", J Trop Pediatr, 51, pp.98~101 (2005)
27. Sammalakorpi K, "Changes in serum lipoprotein pattern induced by acute infection", Metabolism, 37, pp.859~865 (1988)
28. Fraunberger P, "Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock", Shock, pp.359~363 (1998)
29. Terai M, "Prognostic impact of vascular leakage in acute Kawasaki disease", Circulation, 108, pp.325~330 (2003)
30. Taskinen MR, "High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man: evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase", Clin Chim Acta, 112, pp.325~332 (1981)

관련 논문AI추천